Multiplexing spheroid volume, resazurin and acid phosphatase viability assays for high-throughput screening of tumour spheroids and stem cell neurospheres

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Ivanov, Delyan P ^a   Parker, Terry L ^a   Walker, David A ^a   Alexander, Cameron ^a   Ashford, Marianne B ^b   Gellert, Paul R ^b   Garnett, Martin C ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE; ANTINEOPLASTIC AGENT; OXAZINE DERIVATIVE; RESAZURIN; XANTHENE DERIVATIVE;

BIOASSAY; BRAIN; CELL SURVIVAL; CULTURE TECHNIQUE; CYTOLOGY; DRUG SCREENING; HUMAN; METABOLISM; MULTICELLULAR SPHEROID; PROCEDURES; REPRODUCIBILITY; STEM CELL; TUMOR CELL CULTURE; TUMOR CELL LINE; VALIDATION STUDY;

ACID PHOSPHATASE; ANTINEOPLASTIC AGENTS; BIOLOGICAL ASSAY; BRAIN; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL SURVIVAL; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; OXAZINES; REPRODUCIBILITY OF RESULTS; SPHEROIDS, CELLULAR; STEM CELLS; TUMOR CELLS, CULTURED; XANTHENES;

EID: 84905996114     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103817     Document Type: Article

References (68)

1. Arrowsmith J (2012) A decade of change. Nat Rev Drug Discov 11: 17-18. Available: http://dx.doi.org/10.1038/nrd3630.
2. Moreno L, Pearson ADJ (2013) How can attrition rates be reduced in cancer drug discovery? Expert Opin Drug Discov 8: 363-368. Available: http://www.ncbi.nlm.nih.gov/pubmed/23373702. Accessed 2014 Jul 17.
3. Johnson JI, Decker S, Zaharevitz D, Rubinstein LV, Venditti JM, et al. (2001) Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials. Br J Cancer 84: 1424-1431. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2363645&tool= pmcentrez&rendertype=abstract. Accessed 2013 May 28.
4. Conroy S, Garnett M, Vloeberghs M, Grundy R, Craven I, et al. (2010) Medulloblastoma in childhood: revisiting intrathecal therapy in infants and children. Cancer Chemother Pharmacol 65: 1173-1189. Available: http://dx.doi.org/10.1007/s00280-009-1127-1.
5. Abbott A (2003) Cell culture: biology's new dimension. Nature 424: 870-872. Available: http://www.ncbi.nlm.nih.gov/pubmed/12931155. Accessed 2013 Jun 11.
6. Pampaloni F, Reynaud EG, Stelzer EHK (2007) The third dimension bridges the gap between cell culture and live tissue. Nat Rev Mol Cell Biol 8: 839-845. Available: http://www.ncbi.nlm.nih.gov/pubmed/17684528.
7. Page H, Flood P, Reynaud E (2013) Three-dimensional tissue cultures: current trends and beyond. Cell Tissue Res 352: 123-131. Available: http://dx.doi.org/10.1007/s00441-012-1441-5.
8. Breslin S, O'Driscoll L (2013) Three-dimensional cell culture: the missing link in drug discovery. Drug Discov Today 18: 240-249. Available: http://www.ncbi.nlm.nih.gov/pubmed/23073387. Accessed 2013 May 29.
9. Kunz-Schughart LA, Freyer JP, Hofstaedter F, Ebner R (2004) The use of 3-D cultures for high-throughput screening: the multicellular spheroid model. J Biomol Screen 9: 273-285. Available: http://www.ncbi.nlm.nih.gov/pubmed/ 15191644. Accessed 2013 May 25.
10. Mehta G, Hsiao AY, Ingram M, Luker GD, Takayama S (2012) Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy. J Control Release 164: 192-204. Available: http://www.ncbi.nlm.nih. gov/pubmed/22613880. Accessed 2013 May 25.
11. De Witt Hamer PC, Van Tilborg AAG, Eijk PP, Sminia P, Troost D, et al. (2008) The genomic profile of human malignant glioma is altered early in primary cell culture and preserved in spheroids. Oncogene 27: 2091-2096. Available: http://www.ncbi.nlm.nih.gov/pubmed/17934519. Accessed 2012 Mar 9.
12. Sakai Y, Yamagami S, Nakazawa K (2010) Comparative analysis of gene expression in rat liver tissue and monolayer- and spheroid-cultured hepatocytes. Cells Tissues Organs 191: 281-288. Available: http://www.ncbi.nlm.nih.gov/ pubmed/20051666. Accessed 2012 Jun 16.
13. Hirschhaeuser F, Menne H, Dittfeld C, West J, Mueller-Klieser W, et al. (2010) Multicellular tumor spheroids: an underestimated tool is catching up again. J Biotechnol 148: 3-15. Available: http://www.ncbi.nlm.nih.gov/pubmed/ 20097238. Accessed 2013 May 21.
14. Sutherland RM, McCredie JA, Inch WR (1971) Growth of multicell spheroids in tissue culture as a model of nodular carcinomas. J Natl Cancer Inst 46: 113-120. Available: http://www.ncbi.nlm.nih.gov/pubmed/5101993.
15. Messner S, Agarkova I, Moritz W, Kelm JM (2013) Multi-cell type human liver microtissues for hepatotoxicity testing. Arch Toxicol 87: 209-213. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid= 3535351&tool=pmcentrez&rendertype=abstract. Accessed 27 May 2013.
16. Tung Y-C, Hsiao AY, Allen SG, Torisawa Y, Ho M, et al. (2011) High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array. Analyst 136: 473-478. Available: http://dx.doi.org/10.1039/C0AN00609B.
17. Ivascu A, Kubbies M (2006) Rapid generation of single-tumor spheroids for high-throughput cell function and toxicity analysis. J Biomol Screen 11: 922-932. Available: http://www.ncbi.nlm.nih.gov/pubmed/16973921. Accessed 24 May 2013.
18. Friedrich J, Seidel C, Ebner R, Kunz-Schughart LA (2009) Spheroid-based drug screen: considerations and practical approach. Nat Protoc 4: 309-324. Available: http://dx.doi.org/10.1038/nprot.2008.226.
19. Vinci M, Gowan S, Boxall F, Patterson L, Zimmermann M, et al. (2012) Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation. BMC Biol 10: 1-21. Available: http://dx.doi.org/10.1186/1741-7007-10-29.
20. Green JA, Yamada KM (2007) Three-dimensional microenvironments modulate fibroblast signaling responses. Adv Drug Deliv Rev 59: 1293-1298. Available: http://www.sciencedirect.com/science/article/pii/S0169409X07001421.
21. Doublier S, Belisario DC, Polimeni M, Annaratone L, Riganti C, et al. (2012) HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemoresistance of invasive micropapillary carcinoma of the breast. BMC Cancer 12. doi:10.1186/1471-2407- 12-4.
22. Wartenberg M, Ling FC, Muschen M, Klein F, Acker H, et al. (2003) Regulation of the multidrug resistance transporter P-glycoprotein in multicellular tumor spheroids by hypoxiainducible factor-1 and reactive oxygen species. FASEB J 17: 503+. doi:10.1096/fj.02-0358fje.
23. Monazzam A, Razifar P, Lindhe O, Josephsson R, Långström B, et al. (2005) A new, fast and semi-automated size determination method (SASDM) for studying multicellular tumor spheroids. Cancer Cell Int 5: 32. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1315357&tool= pmcentrez&rendertype=abstract. Accessed 2013 Jun 12.
24. Xiao J, Zhang Y, Wang J, Yu W, Wang W, et al. (2010) Monitoring of cell viability and proliferation in hydrogel-encapsulated system by resazurin assay. Appl Biochem Biotechnol 162: 1996-2007. Available: http://www.ncbi.nlm.nih.gov/ pubmed/20437208. Accessed 2013 May 30.
25. Friedrich J, Eder W, Castaneda J, Doss M, Huber E, et al. (2007) A reliable tool to determine cell viability in complex 3-d culture: the acid phosphatase assay. J Biomol Screen 12: 925-937. Available: http://www.ncbi.nlm. nih.gov/pubmed/17942785. Accessed 2013 Jun 11.
26. Keles GE, Berger MS, Srinivasan J, Kolstoe DD, Bobola MS, et al. (1995) Establishment and characterization of four human medulloblastoma-derived cell lines. Oncol Res 7: 493-503. (Pubitemid 26075382)
27. Uchida N, Buck DW, He D, Reitsma MJ, Masek M, et al. (2000) Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci 97 : 14720-14725. Available: http://www.pnas.org/content/97/26/14720.abstract.
28. Yen JC, Chang FJ, Chang S (1995) A new criterion for automatic multilevel thresholding. IEEE Trans Image Process 4: 370-378. Available: http://www.ncbi.nlm.nih.gov/pubmed/18289986. Accessed 2013 Jun 12.
29. Spears CP (1984) Volume doubling measurement of spherical and ellipsoidal tumors. Med Pediatr Oncol 12: 212-217. Available: http://www.ncbi.nlm.nih.gov/ pubmed/6727778.
30. Zhang J-H (1999) A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J Biomol Screen 4: 67-73. Available: http://jbx.sagepub.com/cgi/doi/10.1177/108705719900400206. Accessed 2014 Jan 21.
31. Sittampalam GS (1997) Design of Signal Windows in High Throughput Screening Assays for Drug Discovery. J Biomol Screen 2: 159-169. Available: http://jbx.sagepub.com/cgi/doi/10.1177/108705719700200306. Accessed 2014 Feb 7.
32. Sittampalam G, Gal-Edd N, Arkin M, Auld D, Austin C, et al. (2004) Assay Guidance Manual. Bethesda (MD); Eli Lilly & Company and the National Center for Advancing Translational Sciences. Available: http://www.ncbi.nlm.nih.gov/ books/NBK53196/.
33. Motulsky H, Christopoulos A (2004) Fitting Models to Biological Data using Linear and Nonlinear Regression.
34. Mori H, Ninomiya K, Kino-oka M, Shofuda T, Islam MO, et al. (2006) Effect of Neurosphere Size on the Growth Rate of Human Neural Stem/Progenitor Cells. J Neurosci Res 1691: 1682-1691. doi:10.1002/jnr. (Pubitemid 44892602)
35. Wartenberg M (2001) Tumor-induced angiogenesis studied in confrontation cultures of multicellular tumor spheroids and embryoid bodies grown from pluripotent embryonic stem cells. FASEB J 15: 995-1005. Available: http://www.fasebj.org/cgi/content/abstract/15/6/995. Accessed 2013 Jun 12.
36. Mikhail AS, Eetezadi S, Allen C (2013) Multicellular tumor spheroids for evaluation of cytotoxicity and tumor growth inhibitory effects of nanomedicines in vitro: a comparison of docetaxel-loaded block copolymer micelles and Taxotere. PLoS One 8: e62630. Available: http://www.pubmedcentral.nih.gov/ articlerender.fcgi?artid=3633836&tool=pmcentrez&rendertype=abstract. Accessed 2014 Mar 2.
37. Bez A, Corsini E, Curti D, Biggiogera M, Colombo A, et al. (2003) Neurosphere and neurosphere-forming cells: morphological and ultrastructural characterization. Brain Res 993: 18-29. Available: http://linkinghub.elsevier. com/retrieve/pii/S0006899303035601. Accessed 2013 May 28.
38. Hardelauf H, Frimat J-P, Stewart JD, Schormann W, Chiang Y-Y, et al. (2011) Microarrays for the scalable production of metabolically relevant tumour spheroids: a tool for modulating chemosensitivity traits. Lab Chip 11: 419-428. Available: http://www.ncbi.nlm.nih.gov/pubmed/21079873. Accessed 2014 Mar 2.
39. Mutterer J, Rasband W (n.d.) ImageJ Macro Language Programmer's Reference Guide v1. 46d: 1-45.
40. Introduction into Macro Programming - Fiji (n.d.) Available: http://fiji.sc/wiki/index.php/Introduction-into-Macro-Programming. Accessed 2014 Feb 10.
41. Walenta S, Dötsch J, Mueller-Klieser W (1990) ATP concentrations in multicellular tumor spheroids assessed by single photon imaging and quantitative bioluminescence. Eur J Cell Biol 52: 389-393. Available: http://www.ncbi.nlm. nih.gov/pubmed/2081538. Accessed 2013 Jun 20.
42. Rodríguez-Enríquez S, Gallardo-Pérez JC, Avilés-Salas A, Marín-Hernández A, Carreño-Fuentes L, et al. (2008) Energy metabolism transition in multi-cellular human tumor spheroids. J Cell Physiol 216: 189-197. Available: http://www.ncbi.nlm.nih.gov/ pubmed/18264981. Accessed 2013 Jun 20.
43. Walenta S, Doetsch J, Mueller-Klieser W, Kunz-Schughart L a. (2000) Metabolic Imaging in Multicellular Spheroids of Oncogene-transfected Fibroblasts. J Histochem Cytochem 48: 509-522. Available: http://jhc.sagepub. com/lookup/doi/10.1177/002215540004800409. Accessed 2013 Jun 3.
44. Hande KR (1998) Etoposide: four decades of development of a topoisomerase II inhibitor. Eur J Cancer 34: 1514-1521. Available: http://linkinghub. elsevier.com/retrieve/pii/S0959804998002287?showall=true.
45. Sung KW, Lim DH, Son MH, Lee SH, Yoo KH, et al. (2013) Reduced-dose craniospinal radiotherapy followed by tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk medulloblastoma. Neuro Oncol 15: 352-359. doi:10.1093/neuonc/nos304.
46. Fleischhack G, Reif S, Hasan C, Jaehde U, Hettmer S, et al. (2001) Feasibility of intraventricular administration of etoposide in patients with metastatic brain tumours. Br J Cancer 84: 1453-1459. (Pubitemid 32579334)
47. Pizer B, Clifford S (2008) Medulloblastoma: new insights into biology and treatment. Arch Dis Child Educ Pract Ed 93: 137-144. Available: http://www.ncbi.nlm.nih.gov/pubmed/18809691. Accessed 2010 Jun 28.
48. Krzywinski M, Altman N (2013) Points of significance: Power and sample size. Nat Methods 10: 1139-1140. Available: http://www.nature.com/doifinder/10. 1038/nmeth.2738. Accessed 2014 Jan 21.
49. Campos LS (2004) Neurospheres: insights into neural stem cell biology. J Neurosci Res 78: 761-769. Available: http://www.ncbi.nlm.nih.gov/pubmed/ 15505793. Accessed 2013 Jun 13.
50. Chan GKY, Kleinheinz TL, Peterson D, Moffat JG (2013) A simple high-content cell cycle assay reveals frequent discrepancies between cell number and ATP and MTS proliferation assays. PLoS One 8: e63583. Available: http://dx.plos.org/10.1371/journal.pone.0063583. Accessed 2014 Mar 9.
51. Zamaraeva MV, Sabirov RZ, Maeno E, Ando-Akatsuka Y, Bessonova SV, et al. (2005) Cells die with increased cytosolic ATP during apoptosis: a bioluminescence study with intracellular luciferase. Cell Death Differ 12: 1390-1397. Available: http://dx.doi.org/10.1038/sj.cdd.4401661. Accessed 2014 Jan 22.
52. Katayama M, Kawaguchi T, Berger MS, Pieper RO (2007) DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells. Cell Death Differ 14: 548-558. Available: http://dx.doi.org/10.1038/sj.cdd.4402030. Accessed 2014 Mar 9.
53. Fu X, Wan S, Lyu YL, Liu LF, Qi H (2008) Etoposide induces ATM-dependent mitochondrial biogenesis through AMPK activation. PLoS One 3: e2009. Available: http://dx.plos.org/10.1371/journal.pone.0002009. Accessed 2014 Feb 26.
54. Bowen ID, Lewis GH (1980) Acid phosphatase activity and cell death in mouse thymus. Histochemistry 65: 173-179. Available: http://www.ncbi.nlm.nih. gov/pubmed/6965672. Accessed 2013 Jun 16.
55. Christopoulos A (1998) Assessing the distribution of parameters in models of ligand-receptor interaction: to log or not to log. Trends Pharmacol Sci 19: 351-357. Available: http://www.ncbi.nlm.nih.gov/pubmed/9786022.
56. Eastwood BJ, Farmen MW, Iversen PW, Craft TJ, Smallwood JK, et al. (2006) The minimum significant ratio: a statistical parameter to characterize the reproducibility of potency estimates from concentration-response assays and estimation by replicate-experiment studies. J Biomol Screen 11: 253-261. Available: http://www.ncbi.nlm.nih.gov/pubmed/16490778. Accessed 2014 Jan 23.
57. Toffoli G, Corona G, Basso B, Boiocchi M (2004) Pharmacokinetic optimisation of treatment with oral etoposide. Clin Pharmacokinet 43: 441-466. Available: http://www.ncbi.nlm.nih.gov/pubmed/15139794. Accessed 2013 Jun 16.
58. Slavc I, Schuller E, Falger J, Günes M, Pillwein K, et al. (2003) Feasibility of long-term intraventricular therapy with mafosfamide (n=26) and etoposide (n=11): experience in 26 children with disseminated malignant brain tumors. J Neurooncol 64: 239-247. Available: http://www.ncbi.nlm.nih.gov/pubmed/ 14558599.
59. Bregman CL, Buroker RA, Hirth RS, Crosswell AR, Durham SK (1994) Etoposide- and BMY-40481-Induced Sensory Neuropathy in Mice. Toxicol Pathol 22: 528-535. Available: http://tpx.sagepub.com/cgi/doi/10.1177/019262339402200508. Accessed 2013 Jun 20.
60. Ogasawara H, Kiya K, Kurisu K, Hotta T, Mikami T, et al. (1992) Effect of intracarotid infusion of etoposide with angiotensin II-induced hypertension on the blood-brain barrier and the brain tissue. J Neurooncol 13: 111-117. Available: http://www.ncbi.nlm.nih.gov/pubmed/1432030.
61. Fortin D, McCormick CI, Remsen LG, Nixon R, Neuwelt EA (2000) Unexpected neurotoxicity of etoposide phosphate administered in combination with other chemotherapeutic agents after blood-brain barrier modification to enhance delivery, using propofol for general anesthesia, in a rat model. Neurosurgery 47: 199-207. Available: http://www.ncbi.nlm.nih.gov/pubmed/10917363. Accessed 2013 Jun 20.
62. Faigle R, Song H (2013) Signaling mechanisms regulating adult neural stem cells and neurogenesis. Biochim Biophys Acta 1830: 2435-2448. Available: http://www.ncbi.nlm.nih.gov/pubmed/22982587. Accessed 2013 Jun 3.
63. Zhao C, Deng W, Gage FH (2008) Mechanisms and functional implications of adult neurogenesis. Cell 132: 645-660. Available: http://www.ncbi.nlm.nih.gov/ pubmed/18295581. Accessed 2013 May 23.
64. Rahman CV, Smith SJ, Morgan PS, Langmack KA, Clarke PA, et al. (2013) Adjuvant Chemotherapy for Brain Tumors Delivered via a Novel Intra-Cavity Moldable Polymer Matrix. PLoS One 8: e77435. Available: http://www. pubmedcentral.nih.gov/articlerender.fcgi?artid=3796488&tool= pmcentrez&rendertype=abstract. Accessed 2013 Nov 18.
65. Meng W (2006) Evaluation of a nanparticles drug delivery vehicle medulloblastoma and organotypic brain cell cultures University of Nottingham.
66. Puri S (2007) Novel functionalized polymers for nanoparticle formulations with anti cancer drugs University of Nottingham.
67. Zurich M-G, Stanzel S, Kopp-Schneider A, Prieto P, Honegger P (2013) Evaluation of aggregating brain cell cultures for the detection of acute organ-specific toxicity. Toxicol In Vitro 27: 1416-1424. Available: http://www.ncbi.nlm.nih.gov/pubmed/22954530. Accessed 2013 Jun 21.
68. Moors M, Rockel TD, Abel J, Cline JE, Gassmann K, et al. (2009) Human neurospheres as three-dimensional cellular systems for developmental neurotoxicity testing. Environ Health Perspect 117: 1131-1138. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2717141&tool= pmcentrez&rendertype=abstract. Accessed 2013 May 25.